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Quality of life for patient groups. Along with survival and other ent aspects of the treatment of renal failure include peri-
types of clinical outcome, patients’ quality of life is an important odic assessments of QoL as one of the basic parameters
indicator of the effectiveness of the medical care that they to be considered on evaluating outcomes.receive. Quality of life in patients with end-stage renal disease
Including QoL indicators in patient monitoring is im-(ESRD) is influenced by the disease itself and by the type of
portant not only because it is a basic part of the conceptrenal replacement therapy. Numerous studies have enabled
the identification of the effects of factors such as anemia, age, of health but also because of the close relationship be-
comorbidity, depression, etc. on quality of life. It is possible tween QoL, morbidity, and mortality. This relationship
to counteract many of these effects, and the earlier this is done, is obvious from the many common factors that appearthe more effective the results will be. Among replacement
when these parameters are analyzed [2–4]. Survival istherapies, transplantation appears to be the one that gives the
greater in patients with a better QoL, better performancebest quality of life results for very large groups of patients. In
the case of elderly patients or patients with a high degree of status and less morbidity. This becomes even more im-
comorbidity, the best treatment option should be assessed in portant in elderly patients: in some studies, psychosocial
each individual case, taking all the possible factors into account.
and functional factors are shown to be the most impor-
tant predictors of survival [5, 6].
This paper will briefly review the factors affecting the
End-stage renal disease (ESRD) has a considerable quality of life of renal failure patients receiving the vari-
impact on the functional status and quality of life (QoL)
ous treatment options available as they proceed through
perceived by the patient. Even in relatively early stages,
the various stages of their disease: predialysis, dialysis
it is accompanied by symptoms that affect daily life; renal
and transplant.replacement therapies such as hemodialysis or peritoneal
dialysis only partially correct the uremia and also render
necessary substantial lifestyle changes. A functioning PREDIALYSIS
transplant restores kidney function but it also brings with The number of studies assessing the QoL of patients
it new pathology associated with immunosuppression. prior to initiating dialysis therapy is much lower than
The characteristics of dialysis patients have changed in studies of patients on dialysis. However, there are suffi-
the last 10 years and a growing number of elderly patients cient data on the impact of factors such as the degree
with a considerable degree of comorbidity are receiving of renal insufficiency, anemia, comorbidity, and early
renal replacement therapies. The number of patients control by a multidisciplinary team. Many of the factors
returning to dialysis after a transplant failure is also in- affecting QoL during dialysis already exist in these early
creasing. In many cases, patients receive different types
stages and suitable management of these factors has an
of therapy in the course of their lives. All of these situa-
influence on the course subsequently followed by pa-
tions have varying effects on the quality of life. It is
tients.
broadly accepted that, in addition to the classic parame-
ters such as urea kinetics, albumin, etc., the definition Glomerular filtration rate
of adequate dialysis should also include the quality of
The glomerular filtration rate (GFR) at which the QoLlife experienced by the patient and it is the health teams’
starts to deteriorate is not precisely defined. It variesresponsibility to enable each patient to achieve the maxi-
considerably depending on the underlying disease. Onemum degree of rehabilitation [1]. At present, a large
study of 1284 patients with different degrees of renalnumber of trials throughout the world that study differ-
function concludes that renal insufficiency is associated
with a decrease in the quality of life and an increase in the
severity and frequency of symptoms and psychologicalKey words: quality of life, end-stage renal disease, peritoneal dialysis,
dialysis, renal transplant. distress, and that these symptoms’ severity is correlated
with GFR [7]. 2000 by the International Society of Nephrology
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Comorbidity
Comorbidity appears as a significant factor in several
studies, such as that performed by Harris et al on a
population of 260 patients. The lowest QoL scores are
obtained in patients with the greatest number of associ-
ated diseases, women, unemployed people and people
with low education and income levels [8]. The Spanish
Study Group of the Quality of Life in Chronic Renal
Failure performed a study on 103 predialysis patients.
Plasma creatinine was 5.8 6 1.5 mg/dL. Patients with a
higher degree of comorbidity had significantly lower
scores on the physical and overall dimensions of the
Sickness Impact Profile (SIP) (abstract; Nephrology 3
(Suppl 1): S309, 1997).
Recombinant human erythropoietin
Fig. 1. Mean values of physical and global dimensions in the SicknessThe role played by anemia is well-established. With
Impact Profile (SIP) on predialysis patients treated with rHuEPO (j)the growing use of recombinant human erythropoietin
compared with a control group (not treated, h). Statistical analysis was
(rHuEPO) in the last 10 years, a large number of studies performed using a paired Student’s t-test (*P , 0.01).
have been published showing a significant improvement
in various aspects such as functional capacity, well being,
level of energy and neurocognitive function in treated
cases, close to normal values are the most beneficial.patients [9, 10].
There are no data with regard to predialysis patients,One of the most conclusive studies was the multicenter
but it seems reasonable to ask whether it makes sensestudy carried out by Revicki et al. These authors com-
to let patients develop symptomatic anemia or whetherpared a group of 43 predialysis patients treated with
it would be best to prevent onset of anemia by givingincreasing doses of rHuEPO who attained a hematocrit
rHuEPO and iron in earlier stages of the disease.of approximately 35%, with another group of 40 un-
Recently, Silverberg et al drew attention to the un-treated patients with a similar degree of renal function.
tapped potential of rHuEPO and iron therapy in suchThe QoL was assessed periodically using several instru-
patients [12]. In the United States and Japan, the numberments. In the treated group of patients, a significant
of patients with hematocrits of 24% at initiation of dial-improvement in energy, physical function, activity at
ysis and who were under the care of a nephrologist ishome, social activity and cognitive function was observed
still high, and it is similar to that of patients whose carein parallel with the increase of hematocrit [11].
is not supervised by nephrologists. In Europe in 1993,The Spanish Group carried out a prospective study
an average of 40% of patients had spent the last threeon 103 predialysis patients. Seventy-two were treated
years before starting dialysis with hemoglobin levels be-with subcutaneous rHuEPO and 31 were not treated. In
low 9 g/dL [12].the treated group, the hematocrit increased from 24.8 6
2.7% to 31.4 6 5% after three months, accompanied by
Timing and quality of predialysis treatmenta significant improvement in the Karnofsky Index and
The timing and quality of care in the predialysis phasethe three dimensions of the Sickness Impact Profile (SIP)
is currently acknowledged to be a decisive factor in the(Fig. 1). The categories of the SIP in which the improve-
patients’ morbidity, mortality and QoL. At this time,ment is most marked were sleep, emotional status, body
adequate treatment includes interventions that may slowmovement, sociability and mobility [abstract; Nephrol-
down the progression of renal failure, manage the com-ogy 3(Suppl 1):S309, 1997]. In the untreated group, the
plications of uremia (anemia, high blood pressure, osteo-hematocrit was 29.8 6 4.2% at baseline and 28.9 6 4.5%
dystrophy, malnutrition), choose the dialysis techniqueafter three months and no changes were seen in the QoL
and its preparation (vascular access, peritoneal catheter),scores.
start the replacement therapy in adequate time, and,
Hematocrit last but not least, include the patient in a high-quality
rehabilitation program. This program should cover a num-According to our data, the hematocrit is directly re-
ber of aspects, such as information and psychological sup-lated with the physical dimension of the SIP. The optimal
port for the patient and his/her family, continuation withhematocrit level is currently a subject of debate. In hemo-
dialysis patients, there is already evidence that, in many his/her job, if applicable, and maintenance of the social
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Table 1. QoL indicators in dialysis patients: Mean values of physical,and family roles. These treatments maintain the highest
psychosocial, and global dimensions in the SIP in dialysis patientsa
possible degree of functional capacity, above all in the
Percentilemost disabled patients [13–15]. Patients included in this Typical
Mean SD 25 75type of program continue for longer before requiring dial-
ysis therapy and their treatment compliance is better [16]. Karnofsky Indexb 73 15 60 90
SIPEarly death, morbidity and hospitalization require-
Physical dimension 12 13 2 17ments are greater in patients referred at later stages in
Psychosocial dimension 14 14 4 20
their disease [15]. Sesso studied 113 patients approxi- Global dimensionc 15 12 6 21
mately one month after starting dialysis. The QoL is a N 5 1013
b 31% patients ,60worse in the patients controlled at a late stage by the
c 26% patients SIP .20nephrologists than those who had been diagnosed and
under treatment for more than six months. The most
significant differences are found in depression, relation-
ships, frustration and satisfaction with life, and are partic- function, the likelihood of survival increased 10%. The
impact of the mental function was less, ranging betweenularly marked in elderly patients [17].
There are many barriers that impede early access by 2 and 5.8%. The scores of the patients analyzed by age
group are very similar to those obtained by other groups,patients and adequate preparation. It is likely that one of
the most serious is an insufficient degree of coordination suggesting that these patients answer to a particular
“profile” [20].between primary medical care and hospital care, and
actions tending to improve this coordination may be In 1993, the Spanish Group carried out a study to
assess the QoL of dialysis patients, seeking to identifyuseful. In our department, the percentage of patients
requiring an initial emergency dialysis with a temporary the factors that had the greatest influence on the QoL
[21]. In this study, 1013 patients, currently stable onvascular access has ranged around 15% in recent years,
dialysis, were chosen randomly from 42 centers. Thein some cases due to the absence of prior symptoms or
quality of life instruments used were the self-answeredrefusal by the patient but also, in a significant number
Karnofsky Index (KI) and the SIP. Data were obtainedof cases, due to inadequate management by their primary
on age, sex, etiology of the renal failure, time on dialysis,center [18].
and characteristics of the technique, failed prior trans-
plant and rHuEPO therapy, as well as employment, edu-
DIALYSIS cation and socioeconomic status. Comorbidity was as-
There are many studies that analyze the QoL of dial- sessed using Friedman’s Index, which controls for the
ysis patients, most of whom are on hemodialysis. The presence and severity of 13 possible diseases. The pres-
number of patients studied who are on peritoneal dialysis ence of blindness, claudication or diabetes was recorded.
is much lower. Due to their specific features, diabetic The urea, creatinine, hemoglobin, hematocrit, Kt/V and
patients, elderly patients and those who return to dialysis PCR values were included.
after failure of a renal graft have also been the subject Of the patients in the study, 56% were men, 44%
of various studies. women; 41% were older than 60 years; 96% were under-
In the classic National Kidney Dialysis and Kidney going hemodialysis and 4% peritoneal dialysis; 18% of
Transplantation Study performed on 859 patients, the the patients had undergone a previous, unsuccessful re-
functional measures of dialysis patients were worse than nal graft. The results of the QoL indicators are shown
those of the normal population, although the subjective in Table 1. The overall mean for all patients indicates a
measures were less affected [19]. Transplant, home dial- moderate impairment of the QoL; 26% obtained a score
ysis, and peritoneal dialysis patients obtained better re- equal or greater than 20 in the global dimension of the
sults than patients on hospital hemodialysis. SIP and 31% obtained 60% or less on the KI, indicating
These early data have been confirmed in later studies. a significant effect by the disease. The most severely
The National Kidney Foundation has carried out a pro- affected areas of the SIP are work, free time and hobbies,
spective, two-year study on 1000 patients using the 26- home activities, and sleep and rest.
item Short Form Health Survey Questionnaire (SF-36), There were no differences in the QoL related to the
comparing their results with those of a healthy popula- technique, type of buffer or membrane, Kt/V or PCR.
tion composed of 2474 subjects. The physical function is Higher hemoglobin levels were related to better QoL
the most severely affected while the mental function is scores on physical and global dimension of the SIP. A
the closest to normal. In its data, the performance status higher socioeconomic or educational status was associ-
has the same predictive value on mortality and hospital- ated with better scores. Elderly patients and those with a
ization as Kt/V and normalized protein catabolic rate higher degree of comorbidity showed a lower functional
capacity and a greater impact of the disease on their QoL.(nPCR) [3]. With each 5-point increase in the physical
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SF-36 in 484 patients who started treatment with
rHuEPO and compared them with another group of 520
patients already under treatment. At baseline, untreated
patients scored lower than treated patients. However,
the differences narrowed progressively as the hematocrit
increased [26].
In Spain, Moreno et al compared the QoL of 57 pa-
tients starting treatment with rHuEPO with a control
group of 29 patients who did not require therapy; in the
treated group, the correction of the anemia was associ-
ated with a significant improvement on all three dimen-
sions of the SIP [27].
The optimal hematocrit to be maintained in dialysis
patients continues to be the subject of debate. Five years
ago, Eschbach postulated that patients were insuffi-
ciently treated, with target hematocrits around 30% in
Fig. 2. Hemoglobin levels and values of physical (j) and global (h) most centers. Among the possible causes for this would
dimensions in the Sickness Impact Profile (adjusted for age, comorbidity
be the lack of objective studies on the benefits of higherindex, gender, socioeconomic, and educational level). Statistical analysis
was performed using covariance analysis (*P , 0.01; **P , 0.05). hemoglobin levels, an incorrect assessment of the mor-
bidity associated with anemia, and the high cost of
rHuEPO [28]. The hematocrit level currently recom-
mended by the National Kidney Foundation DialysisFemale gender and diabetes are factors that correlate
Outcomes Quality Initiative (DOQI) guidelines is 33–negatively with the global and physical dimensions of
36% [29].the SIP.
Studies performed in small groups of patients whoThe Italian group DIA-QoL, when administering the
received treatment to increase the hematocrit up to 42%SF-36 to 300 patients, also observed lower scores in
showed improvements in QoL, exercise capacity andwomen, while age and diabetes were the physical aspects
heart function (abstract; J Am Soc Nephrol 4:8, 1993),having the greatest effect. They found a relationship be-
and an improvement in cerebral blood flow [30]. Ourtween albumin levels and the questionnaire’s physical di-
group has performed a prospective, controlled study onmensions. Upon comparing their data with age-matched
the effects of restoring normal hematocrit values on QoLgroups from the general population, dialysis patients ob-
tained lower scores, particularly in the physical aspects. [31]. Stable patients aged between 18 and 65 years and
In the case of elderly patients, the differences are less, hematocrits between 28 and 35% were included. The
particularly in the mental aspects [23]. target was a 5-point increase in the hematocrit. The ex-
Diabetic patients obtain poorer results than nondia- clusion criteria were diabetes, uncontrolled arterial hy-
betic patients for all age groups in all the studies. In pertension, malfunction of the vascular access, severe
their case, comorbidity is the main determinant. Diabetic comorbidity, history of heart failure, ischemic heart dis-
patients comprise a more vulnerable patient group and ease, stroke or seizures. Doses of rHuEPO were doubled
special effort should be devoted to them to improve their in patients receiving less than 60 IU/kg per week and
rehabilitation [21, 22]. were increased 50% in those receiving more than 60
In the above-mentioned study carried out by the Span-
IU/kg per week. The SIP and the KI were used as QoL
ish Group, hemoglobin levels are significantly related
indicators and the study’s duration was six months.with the global and physical dimensions of the SIP, as
One hundred and fifty-six patients were included inFig. 2 shows. The role of anemia in the QoL, as appearing
the study. Of these, 7 withdrew due to transplant, 12in our data, is well known. The results of several multi-
failed to show at least a 4-point increase in hematocritcenter studies on the QoL of rHuEPO-treated patients
figures, and 10 were lost to follow-up. Twelve patientswere published the early 1990s [23–25]. The target hema-
were censored due to adverse effects, and 115 completedtocrits varied but, in all studies, the patients’ functional
the six months follow-up period. The mean age of thecapacity, energy and activity level, sleep, mobility, appe-
patients was 44 6 15 years and the duration of dialysistite, social relationships, perceived state of health and
therapy before the study was 37 6 40 months. The base-decrease in the standard list of symptoms, such as dys-
line hematocrit was 31 6 0.9%, and increased to 39 6pnea, anxiety and muscle fatigue, improved significantly.
Beusterien et al studied the changes observed in the 2% after six months. A significant improvement was
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best for the myocardium. Furthermore, different patient
groups (diabetics, elderly patients, patients with heart
disease, sedentary/active patients) may have different
requirements [34].
Depression is a factor to be taken into account when
analyzing our patients’ QoL. Prevalence of depression
varies in the dialysis population between 70% if the Beck
Depression Inventory is used and 6–18% if the criteria
of the American Psychiatry Society are applied [35, 36].
It is more common in women, as is also the case in the
general population. This could account in part for the
poorer results obtained by women in the various QoL
studies. Depression has a significant impact on percep-
tion of the QoL and it may mask the results obtained with
Fig. 3. Mean values of physical, psychosocial and global dimensions
assessment instruments that do not take into account thein the Sickness Impact Profile on patients at the beginning of the study
(h) and six months after ( ), when hematocrit level was increased from possibility of subclinical depressions [26]. It is important
31 6 0.9% to 39 6 2%. Statistical analysis was performed using the to use simple instruments that enable depression to be
Wilcoxon test (*P , 0.01; **P , 0.001).
detected so that suitable treatment can be given.
Some groups have studied the impact of short-dura-
tion, daytime or nighttime dialysis 6–7 times a week
on the QoL. This dialysis schedule improves metabolicobserved in all three dimensions of the SIP (Fig. 3) and
the KI. The hospitalization rate fell significantly. This control, dialysis-related symptoms, and social, sexual,
and physical function [37, 38]. The long-term results havehas also been reported in other studies [32]. Three pa-
tients were censored from the study due to uncontrolled yet to be assessed but it may provide a useful alternative
for patients with severe heart disease, autonomic nervousarterial hypertension and nine due to fistula thrombosis;
these rates are in line with usual findings. This study system disease or diseases that cause poor tolerance.
The employment status of working-age patients has ashows that, in selected patients, restoring normal hema-
tocrit values induces a marked improvement of the QoL, major influence on their rehabilitation. In a number of
series, the proportion of patients who continue workingwithout adverse effects.
The results of the North American multicenter study is low, between 19 and 30% [39, 40]. In addition to
disease-related factors, there are no doubt many otherpublished recently by Besarab et al [33] show the need
for further research in this area. They studied 1233 dial- factors that are equally important or more so, such as
the situation of each country’s labor market. However,ysis patients with a background of ischemic heart disease
or congestive heart failure. The rHuEPO dose was in- it is important to keep patients as fit as possible right
from the predialysis stage so that, if they lose their jobs,creased in one half of the group to hematocrit values
of 42% while the other half was kept at hematocrit values it is not because of physical problems, which would make
it much more difficult for them to reenter the labor mar-of 30%. The QoL, as assessed with the SF-36, improves 0.6
points on the physical level for each percentage point ket. In the case of transplant patients who rate their state
of health as perfect, their employment situation is veryincrease in the hematocrit, without any significant
changes in the other scores. Mortality and the frequency similar to that held during dialysis, thus showing the im-
portance of preventing patients from leaving work [39].of myocardial infarctions after 2 years were higher in
the normal hematocrit group (normal/low risk rate 1.3), The number of studies of the QoL of peritoneal dial-
ysis patients is low. In the previously mentioned studyand consequently the study was stopped. However, in
both groups, the mortality rate was lower at high hemato- by Evans [19], continuous ambulatory peritoneal dialysis
(CAPD) patients gave somewhat better results than pa-crit levels. After analyzing their data, the authors of this
study were unable to find an explanation for their results, tients on hospital hemodialysis. Simmons et al analyzed
a group of 150 CAPD patients and another group ofconcluding that restoring normal hematocrit values is
not to be recommended in such patients [33]. 83 patients on in-center hemodialysis with respect to
different indicators. The CAPD group scored higher onGiven these conflicting results, the optimal hematocrit
to be targeted with rHuEPO has yet to be defined. In the physical, social and emotional dimensions [41]. More
recently, an Italian multicenter study of patients on hos-theory, it would be the value that maximizes survival,
cardiovascular function and daily life activities with mini- pital hemodialysis, automatic peritoneal dialysis and con-
tinuous peritoneal dialysis showed a greater degree ofmal risk. The different organs may respond differently
to improvements in the degree of anemia and the best independence and more positive attitudes among the
peritoneal dialysis patients, although with a greater de-hematocrit for the brain need not necessarily be the
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gree of anxiety and insecurity than the hemodialysis pa- the best option [19, 48]. This idea is also very widespread
among patients and is a very common request whentients [42]. These studies are cross-sectional, there are
no controlled, randomized studies assessing the specific starting treatment. When assessing inclusion or not of
elderly patients, with a significant degree of comorbidityimpact of the technique itself. Anemia, comorbidity and
employment are factors influencing the QoL, as in hemo- or with a previous transplant failure, on transplant wait-
ing lists, one of the variables to be considered will bedialysis.
Age affects the QoL, but it probably softens the impact the foreseeable impact on their QoL.
A number of cross-sectional studies have been carriedof the renal failure. When groups of dialysis patients are
compared with healthy populations, the older age groups out on numerous groups of patients, where the QoL has
been compared simultaneously in groups of dialysis andobtain scores that are nearer to normal than the younger
age groups [2]. They report more satisfaction with their transplant patients, such as the study mentioned pre-
viously by Evans et al [19]. The results show an improvedlife on dialysis and accept the limitations it imposes more
readily than the younger age groups. Eighty percent of functional status, greater well being and more satisfac-
tion with life for transplant patients than for those receiv-the elderly patients recommended dialysis to patients of
their age, compared with 12.5% who would advise in ing the different types of dialysis. Bremer et al and Sim-
mons et al in 1990, reported similar results in 489 andfavor of refusing it [43]. The functional situation in this
patient group is related significantly with the mortality 756 patients, respectively [45, 49]. Both studies include
a multidimensional assessment, in terms of physical,risk [5]. It is vital to include these elderly patients in
programs preventing progressive invalidity, with specific emotional and social well being, resumption of work,
and sexual and family life. Transplant patients and homephysiotherapy regimens, periodic assessment of the men-
tal status, meetings with relatives or caregivers, etc. This dialysis patients obtain higher scores on the subjective
QoL indicators than hospital or peritoneal dialysis pa-would enable early detection of changes that are not
readily visible in a clinical setting, such as subclinical tients. In some fields, transplant patients even score
higher than the general population. In some objectivedepressions or decreased involvement in daily and family
aspects, such as sexual activity or employment, there arelife activities, which may be potentially reversible [20].
also differences in favor of the transplant.Some projects, such as those sponsored by the Life Op-
However, in these studies, the groups compared aretions Council in the United States, show the importance
often not matching in features such as age, comorbidityof maintaining and improving patients’ physical capacity,
and socioeconomic status. All of these variables have aparticularly in the high-risk groups, such as those with
significant impact on QoL and may be responsible ina high degree of comorbidity or elderly patients [44].
part for the differences found between the differentAn increasing number of patients are returning to
treatment groups. Furthermore, access to transplant isdialysis after a failed transplant. The impact of the loss
conditional on many of these variables. Gaylin et al ana-of the graft on the QoL is controversial. In some studies,
lyzed a sample of 4118 patients starting dialysis in theit appears as a very negative factor [45], both on subjec-
United States between 1986–1987. The lowest transplanttive measures and on other objective measures such as
rates are associated with cardiovascular disease and de-employment. In one group of 95 transplant candidates,
mographic factors such as age, female sex, black race,56% refused it. In 92% of these patients, the reason
and financial status [50]. Exclusion criteria vary fromgiven was a previous transplant failure [46]. However,
one country to another and some of them, such as age,in other studies, failure of a transplant does not seem to
have been the subject of review. However, there is noaffect the QoL [19]. The differences may be explained
doubt that they have impacted the results of the cross-in part by differences in the evolution of the graft. Those
section studies performed as, to a certain extent, trans-patients for whom the loss of the kidney graft has been
plant patients are a preselected group [51].traumatic, with a prolonged period of complications until
In other studies, QoL of transplanted patients hasdialysis is resumed, show a greater negative impact on
been analyzed at a specific time during their clinicaltheir QoL than those for whom the process has been
course [45, 52]. In 316 patients transplanted between 2quicker and with a lesser degree of associated morbidity
and 8 years ago, Witzke observed an 87.5% improvement[47]. In the above-mentioned study by the Spanish
in QoL; 41% rated their physical condition as good andGroup, a transplant failure was not related with a lower
73% reported an excellent mental health [53].QoL [21].
The results of prospective, longitudinal studies analyz-
ing the QoL of dialysis patients who subsequently re-
KIDNEY TRANSPLANTATION ceived a functioning kidney transplant have contributed
Since the early studies assessing QoL of patients un- highly significant data that confirm that for a large major-
dergoing different types of replacement therapy for renal ity of patients, the transplant has improved their QoL,
with each patient acting as his/her own control. In 1981,failure, the functioning transplant has always appeared as
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although there is a tendency towards improvement in
all the indicators, it is only statistically significant in the
global dimension (P , 0.05). These findings are not cor-
related with age, kidney function, comorbidity or immu-
nosuppression schedule, which are similar in both sexes.
Among the possible explanations, in addition to the pos-
sibility mentioned previously of the higher frequency
of more-or-less latent depressive states in women, the
employment situation could also play a role. In some
studies, such as that of Simmons et al return to work is
less frequent in women than in men and could account
for some of the differences found [49].
In this study, age and comorbidity had a considerable
influence on changes in QoL after transplantation. The
Fig. 4. Mean values of physical, psychosocial and global dimensions 22 patients older than 55 had a less favorable coursein the Sickness Impact Profile in transplanted patients (h) compared
with regard to QoL than the younger patients; althoughwith the previous results on dialysis (j). Statistical analysis was per-
formed using a paired Student’s t-test (*P , 0.001; **P , 0.01). they tend to improve on all three dimensions of the SIP,
the difference is significant only on the global dimension.
In other studies, age has not had any negative impact
on the results; in the group studied by Lapaucis, patients
Simmons et al observed an improvement in the physical aged over 60 progressed equally well as the rest [59].
and emotional well being and status of 148 patients, most Given the growing number of patients over 60 and 70
of whom had received a kidney from a live donor [54]. starting dialysis each year—many of whom wish to re-
Similar results are reported by other authors in small ceive a transplant—it is important to not exclude them
groups of patients [55–57]. There is an overall improve- a priori for this reason alone. Although this group’s im-
ment in QoL indicators, including a decrease in depres- mediate mortality and morbidity is higher than the
sion, although anxiety levels are similar to those ob- younger age groups, the long-term results are good. The
served during dialysis, probably caused by the fear of decision to include them or not on the waiting list should
losing the graft. Improvements are observed in sleep and take into account the patient’s wishes and the changes
appetite disorders and sexual dysfunction [58]. Lapaucis that can be expected in the QoL, in addition to a thor-
et al observed an improvement in QoL indicators of 136 ough cardiovascular assessment.
patients six months after receiving a transplant. This There are many reasons for the improvement in the
improvement was still observed in 77 patients who were QoL after transplant and they all occur simultaneously.
studied again two years later [59]. Consequently, it is difficult to know each one’s specific
Hilbrands et al observed a progressive improvement weight. On a physical level, the correction of the ane-
starting from the third month after transplant in 120 mia—mentioned previously—has a definite effect on
cases. This improvement appears on all three dimensions QoL, leading to the disappearance of symptoms such as
of the SIP and on a depression scale and attains values fatigue, sleep and appetite disorders, etc. [10]. Normal
similar to those of the general population. Acute or levels are restored of a series of substances, many of
chronic rejection events have a negative impact [60]. them incompletely understood, which lead to a physical
The Spanish Group of the QoL in Renal Failure exam- improvement. On many occasions, patients who had
ined the changes occurring in QoL of 93 patients who been unable to identify a series of subclinical disorders
had been studied beforehand while they were on dialysis are able to recognize them once they have disappeared.
in 1993 and who had received a transplant during the There is an improvement in sexual disorders—women
following two years [61]. The self-answered KI and the resume menstruation and recover their fertility while
SIP were used as QoL indicators. Overall, the 88 patients men recover their sexual potency and libido—which has
with a functioning transplant showed a significant im- a positive impact on QoL [64, 63]. An improvement in
provement in QoL indicators, both in the KI and on the neurocognitive activity has been described with trans-
three dimensions of the SIP (physical, psychosocial and plantation that is superior to that observed with partial
global) (Fig. 4). The improvement appears in all catego- correction of anemia with rHuEPO [64]. Fluid intake
ries of the SIP and is very marked in some, such as sleep, and diet restrictions are lifted. On a psychological and
emotional status, mobility and nutrition. As has already social level, the physical dependence on the machine
been mentioned for hemodialysis, female patients show disappears and the patient has more freedom of move-
the least favorable course. Men improve significantly on ment. In many cases, an improvement in social and fam-
ily adjustment is observed.the KI and all three dimensions of the SIP. In women,
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Resumption of work is a highly significant component bone pain. Many of them may have a greater effect on
of QoL. In this respect, the results published very consid- women’s QoL and account for some of the differences
erably depending on the series, from 30% to 60% [39]. found [67]. Protocols have been devised to compare the
Each country’s specific factors are very important, the effects on the QoL of different immunosuppression
availability of welfare benefits and the employment rates schedules with prednisone, azathioprine or cyclosporine
have just as great an effect as the patient’s health on as monotherapy or combined with prednisone. The num-
the possibilities of finding a job. Of the 226 transplant ber of patients is small and does not allow any definite
patients studied by Manninen et al, 62% consider them- conclusions to be drawn, although there would be a trend
selves fit for work, but only 43% are actually working towards a better situation in patients not receiving ste-
[65]. Matas et al obtained data on the employment or roids [60]. Simmons et al reported a better QoL in pa-
education status of 733 patients before and after trans- tients treated with prednisone and cyclosporine com-
plantation. The most decisive factor is the pre-transplant pared with those treated with azathioprine/prednisone/
situation, which means that there are no changes in most antilymphocyte globulin, which is related in turn with a
cases; approximately 15% of the patients who received lower number of rejection events and infections [49].
pensions before the transplant have resumed employ- There are no data published yet on the effect of new
ment or studies [40]. immunosuppressive drugs such as mycophenolate or ta-
There are few data available on the evolution of the crolimus on the QoL.
QoL of transplant patients over time. In the studies men- As has already been mentioned, diabetic patients
tioned, the period of assessment of transplant patients make up a separate group. Their QoL on dialysis is
ranges from a few months to nine years, but in most of usually worse than that of the other patients. Their treat-
them, serial sections have not been performed. Parfrey ment alternatives are kidney transplant alone or, in the
et al studied 67 transplant patients with a 1-year gap case of type I diabetics, double kidney-pancreas trans-
between each assessment; the subjective and objective plant, although the number of centers offering this kind
assessment of QoL does not vary, showing slight im- of transplant is much less than the number of centers
provements in some aspects [56]. Gorlen et al studied offering kidney transplantation alone. The morbidity and
31 patients with a functioning transplant implanted a immediate hospital stay are much greater in the dual
mean of 16 years before the study (range 10–22 years). transplant and, although in the long term the functioning
Sixty-four percent of them describe their overall situa- pancreas improves the course of the neuropathy, the
tion as very good or good, 29% describe it as fair and results as regards micro- and macrovascular disease are
6% as poor [66]. In the above-mentioned study of the less conclusive. Consequently, in order to define the posi-
Spanish group, 35 patients were reassessed using the
tive and negative aspects, studies have been carried out
same QoL instruments three years later, with a mean
comparing the effect of the double transplant and thepost-transplant time of 54.3 6 7.3 months. In men, the
kidney transplant alone on QoL. Sechi et al studied 29QoL results remain stable with respect to the first trans-
double transplant patients, comparing them with 14 kid-plant period, with significant improvements on all three
ney transplant patients and 48 dialysis patients [69]. Thedimensions of the SIP compared with the situation dur-
two groups of transplant patients obtained better scoresing dialysis. However, women show a deterioration of
on the physical QoL indicators than the dialysis patients;the SIP scores to levels similar to those obtained during
with regard to the psychological indicators, the kidney-dialysis. It should be pointed out that these patients’
pancreas transplant patients showed higher levels of af-predialysis situation was very good, with a mean KI of
fect, social well being and satisfaction with life. The items80 6 13.6. It seems reasonable to think that in the initial
related with glycemia control are significantly better inperiod after transplant, the subjective assessment of the
the double transplant patients. Anxiety levels are similarQoL would show the change more sharply than later on,
in all three groups, suggesting that the anxiety generatedonce the patient has adapted the new situation. A num-
by the dialysis is replaced by anxiety about a possible lossber of different factors may influence the long-term
of the graft. They conclude that the double transplantcourse of QoL after transplantation, including the pa-
gives an extra degree of quality of life to the diabetictients’ prior psychological features and the side-effects
patient that is superior to that of the kidney transplantof the immunosuppressive therapy. Patients having a
alone. Gross et al studied 154 patients pretransplant andneurotic or emotionally unstable personality or de-
after 1 year; of these, 89 patients received a kidney trans-pressive patients tend to somatize more and place more
plant and the other 65 patients received a combined kid-emphasis on the negative effects of the transplant than
ney-pancreas transplant [70]. After 1 year, both groupson the positive effects [67, 68]. These negative effects
reported a significant improvement in their state of health.are related to a great extent to immunosuppression and
The recipients of the double transplant scored better onmay appear in up to 82% of patients. The most common
effects are weight gain, gum hyperplasia, hirsutism, and the satisfaction scale based on the Diabetes Control Com-
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and assessment of quality of life in hemodialysis patients. Nephrolplications Trial; the reasons are dietary flexibility, less time
Dial Transplant 12:2111–2115, 1997
spent on health care and less family impact. 18. Gomez Campera F, Jofre R, Tejedor A, Lopez Gomez JM: La
primera dia´lisis en el paciente con insuficiencia renal cro´nical.
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